News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Anirban Maitra: Mapping the tumor phenotypes and immune compositions of primary and metastatic breast cancers
Anirban Maitra/X
Oct 28, 2024, 13:31

Anirban Maitra: Mapping the tumor phenotypes and immune compositions of primary and metastatic breast cancers

Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a post on X:

“From the lab that invented imaging mass cytomtery (IMC) comes this new Cancer Research paper on mapping the tumor phenotypes and immune compositions of primary and metastatic Breast Cancers.

Fantastic resource of an optimized 75 marker IMC panel for interrogating solid cancers.”

Anirban Maitra

Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes.

Authors: Laura Kuett, Alina Bollhagen, Sandra Tietscher, Bettina Sobottka, Nils Eling, Zsuzsanna Varga, Holger Moch, Natalie de Souza, Bernd Bodenmiller.

Anirban Maitra: Mapping the tumor phenotypes and immune compositions of primary and metastatic breast cancers

Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.

Alina Bollhagen Anirban Maitra Bernd Bodenmiller Bettina Sobottka breast cancers cancer Cancer research Holger Moch imaging mass cytomtery IMC Laura Kuett metastatic breast cancers Natalie de Souza Nils Eling OncoDaily Oncology Sandra Tietscher Zsuzsanna Varga
Special Coverage
Dialogues
Jan 21, 2025, 18:50
Global Cancer Movement: Novel Epithelial Phenotypes in Colorectal Cancer
Blog
Jan 21, 2025, 17:35
ESO - Enhance clinical skills and gain best practices of oncology with M2ICOS project care standards
Blog
Jan 21, 2025, 17:32
European Society of Gynaecological Oncology - Advancing Women's Health in Europe Through Advocacy
Blog
Jan 21, 2025, 17:23
SIOP Europe Lifetime Achievement Award celebrates those making an impact to the paediatric oncology field
Career
Jan 21, 2025, 17:16
Victor E. Velculescu - Candidate for President Elect of AACR
Insight
Jan 21, 2025, 17:14
Esosa Omoregie: Our lab's latest work on Aquaporin 12 expression in the Stomach and Liver of the Spiny Dogfish
Insight
Jan 21, 2025, 17:03
Irene Ghobrial: Deeper response predicts better outcomes in high-risk-smoldering-myeloma
Insight
Jan 21, 2025, 17:00
5 papers about lung cancer by Stephen Liu
Blog
Jan 21, 2025, 16:54
Jessica Whorton: Cancer survivors don’t need sympathy at work - we need a seat at the decision-making table
Blog
Jan 21, 2025, 16:45
Engaging communities forgotten by cancer research in LMICs and at the NCI - SIOP
Insight
Jan 21, 2025, 16:40
Maryam Lustberg: More studies are necessary to define the implications of clonal hematopoiesis in breast cancer
Blog
Jan 21, 2025, 16:35
Tracey O'Brien: Cancer Institute NSW’s skin cancer campaign has prevented more than 2200 skin cancers